The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

DVT Prophylaxis — Preventing Venous Thromboembolism in the Critically Ill

Reducing VTE risk in intensive care through a combination of mechanical and pharmacological prophylaxis.

Written by: Saygı Hospital Health Guide Editorial Board
Published: · Last updated:

This content is for general information; please consult your physician for diagnosis and treatment.

References (3)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Kardiyoloji department. Book Appointment →

What is DVT Prophylaxis — Preventing Venous Thromboembolism in the Critically Ill?

In critical illness, the incidence of venous thromboembolism (VTE — deep vein thrombosis + pulmonary embolism) reaches 10-30% without prophylaxis. Immobilization, sepsis, mechanical ventilation, central venous catheters, sedation, trauma, and malignancy multiply VTE risk.

ACCP 9th edition (2012) and ASH (American Society of Hematology) guidelines recommend routine VTE prophylaxis in critically ill patients. Pharmacological prophylaxis is standard; in cases of high bleeding risk, mechanical prophylaxis is used (with a transition to pharmacological therapy once bleeding risk decreases).

Prophylaxis options — Low-Molecular-Weight Heparin (LMWH — enoxaparin 40 mg SC/day, dalteparin 5000 U SC/day), unfractionated heparin (UFH) 5000 U SC 2-3×/day, fondaparinux 2.5 mg SC/day (if HIT history), with dose adjustments based on weight/GFR.

Mechanical prophylaxis — Intermittent Pneumatic Compression (IPC — most effective mechanical modality), Graduated Elastic Compression Stockings (GCS), combined (IPC + pharmacological) in high-risk patients. The CLOTS 3 trial demonstrated IPC's effectiveness in stroke.

Symptoms

All ICU admissions — VTE risk assessment in the first 24 hours (Padua, IMPROVE, Caprini scores)
High-risk situations — active malignancy, prior VTE, severe sepsis, trauma/burns, advanced age (>75), spinal-cord injury, thrombophilia
Moderate risk — general surgery, cardiac surgery, mechanical ventilation, severe obesity
Low risk — mobile, short-stay, young, no comorbidities (prophylaxis still recommended in ICU)
DVT suspicion — extremity swelling, warmth, erythema, pain (low specificity — confirm with Doppler ultrasound)

Risk Factors

High bleeding risk — platelets <50 000, active bleeding, GI bleeding, intracranial hemorrhage, recent major surgery, postoperative neurosurgery within 24 hours
HIT (Heparin-Induced Thrombocytopenia) — heparin-PF4 antibodies; platelet drop + thrombosis; alternatives: argatroban, fondaparinux
Renal failure (GFR <30) — LMWH accumulates; reduce dose (enoxaparin 30 mg/day) or prefer UFH
Obesity (BMI >40) — LMWH dose adjustment (enoxaparin 40 mg twice daily or weight-based)
Pregnancy — LMWH preferred; warfarin contraindicated; includes postpartum period

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Routine risk stratification at ICU admission — Padua or IMPROVE score
  • Bleeding risk (low platelets, active bleeding) — mechanical prophylaxis + monitoring; add LMWH when platelets recover
  • VTE develops (suspected DVT/PE) — Doppler ultrasound / CTPA; initiate therapeutic anticoagulation

Treatment Methods

01
Risk assessment — Padua ≥4 or IMPROVE ≥4 indicates high risk; most critically ill patients fall into the high-risk category
02
Pharmacological prophylaxis (standard) — enoxaparin 40 mg SC/day (GFR >30), dalteparin 5000 U SC/day, UFH 5000 U SC 2-3×/day (GFR <30 or marginal bleeding risk)
03
Mechanical prophylaxis — Intermittent Pneumatic Compression (IPC — pneumatic boot, foot cuff, leg sleeve) preferred 24/7; graduated elastic stockings acceptable as an adjunct; combination in high-risk patients
04
Special situations — obesity (enoxaparin 40 mg twice daily), HIT (argatroban 0.5-2 mcg/kg/min, fondaparinux 2.5 mg SC/day, bivalirudin), pregnancy (LMWH preferred), renal failure (dose adjustment or UFH)
05
Duration — throughout the ICU stay, up to extubation/mobilization; for selected high-risk patients (cancer, major surgery), extended prophylaxis for 4 weeks post-discharge
06
Monitoring — daily platelets (HIT screening, particularly on days 5-10), signs of bleeding (GI, skin, hematuria), DVT findings (limb swelling/pain), anti-Xa level (in obesity, pregnancy, severe renal failure)

Which Department to Visit?

You can visit our Kardiyoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Kardiyoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Hypertension (High Blood Pressure)

Kardiyoloji

Hypertension is a condition in which blood pressure readings remain above 140/90 mmHg; early treatment helps prevent serious complications.

Coronary Artery Disease

Kardiyoloji

Narrowing of the coronary arteries due to atherosclerosis can cause chest pain (angina) and heart attack.

Heart Failure

Kardiyoloji

Heart failure is a chronic cardiac condition characterized by shortness of breath, leg swelling, and fatigue.

Heart Attack (Myocardial Infarction)

Kardiyoloji

A heart attack is a medical emergency; because heart muscle is lost by the minute, immediate intervention saves lives.

Atrial Fibrillation

Kardiyoloji

Atrial fibrillation is a common arrhythmia characterized by an irregular heartbeat and increased risk of stroke.

Heart Palpitations

Kardiyoloji

Palpitations are usually due to benign causes, but underlying cardiac rhythm disorders must be ruled out.

Heart Valve Diseases

Kardiyoloji

Valve stenosis or regurgitation increases the workload of the heart and, over time, can lead to heart failure.

Aortic Aneurysm

Kardiyoloji

Aortic aneurysms are often silent; early diagnosis allows treatment before rupture (a life-threatening tear).

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.